The World Health Organization has approved the Chinese vaccine, Synovik

The World Health Organization (WHO) has approved the Chinese synovic code vaccine, but this permission is subject to emergency use.

This is the second Chinese vaccine to be approved after cyanoform. Synovik is already used in many countries around the world for people over the age of eighteen. However, the WHO explained that the use in emergencies meant that “vaccines now have to meet further international standards in terms of safety, efficacy and preparation.”

However, some experiments and results on the Synovik vaccine have shown that more than half of those vaccinated survived corona’s outward symptoms, while 100% survived corona’s severe symptoms and hospitalization.
On this occasion, the WHO was of the view that in order to provide a non-discriminatory vaccine in the world, it is necessary to approve more than one vaccine so that a large number of people can benefit from it. So far, 600 million doses have been given worldwide, according to Synovik.